The Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) is the first national research institute in Germany focusing on biomedical research on human aging, a multifactorial process controlled by environmental and genetic factors.
This website will provide you with an insight into our institute, the research we do and the faces behind FLI's science activities. We wish you an exciting and entertaining voyage of discovery into the world of aging research at FLI.
Covid-19: Operating mode “New Normality” at FLI - Phase D
The Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) has been in minimal operation mode (Phase A) from March 23 - April 19, 2020. The aim of this measure was to limit the spread of the corona virus and protect our staff from possible infections by this virus.
Since April 20, the FLI gradually began to return to normal operation mode (Phase B & C). In compliance with all regulations and legal obligations, some amount of experimental scientific research has made possible again at FLI.
Since June 1, the FLI entered Phase D, in which we will operate under conditions that should last for an extended period of time. Our first priority remains the health of our employees, to ensure the wellbeing of our laboratory animals and to prevent further spread of the corona virus as far as possible.